{"entity":{"type":"insider","cik":"0001459708","url":"/insider/0001459708","json_url":"/insider/0001459708.json","name":"21 APRIL FUND, LTD.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":76,"n_filings":31,"first":"2010-06-22","last":"2019-06-24","span_basis":"filed_date"},"name_variants":[{"name":"21 APRIL FUND, LTD.","source":"filing","n_filings":23,"first_seen":"2016-04-27","last_seen":"2019-06-24"},{"name":"21 APRIL FUND LTD","source":"filing","n_filings":8,"first_seen":"2010-06-22","last_seen":"2016-01-12"}],"transactions":[{"id":7903755,"accession":"0001567619-19-013856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-013856","line_url":"/filing/0001567619-19-013856#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; 21 APRIL FUND, L.P.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000000.0,"shares_display":"4,000,000","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":2080000.0,"total_display":"2,080,000.00","shares_owned_after":26476546.0,"shares_owned_after_display":"26,476,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider"},{"id":6411105,"accession":"0001140361-18-022203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-022203","line_url":"/filing/0001140361-18-022203#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Investment Management, LLC; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":4.549,"price_display":"4.55","price_state":"stated","total_value":40941.0,"total_display":"40,941.00","shares_owned_after":4949355.0,"shares_owned_after_display":"4,949,355","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-04","filed_date":"2018-05-08","scope":"insider"},{"id":6653982,"accession":"0001140361-18-021543","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-18-021543","line_url":"/filing/0001140361-18-021543#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.6595,"price_display":"4.66","price_state":"stated","total_value":232975.0,"total_display":"232,975.00","shares_owned_after":4940355.0,"shares_owned_after_display":"4,940,355","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-03","filed_date":"2018-05-03","scope":"insider"},{"id":6653979,"accession":"0001140361-18-021543","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-021543","line_url":"/filing/0001140361-18-021543#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55700.0,"shares_display":"55,700","price_per_share":4.7171,"price_display":"4.72","price_state":"stated","total_value":262742.47,"total_display":"262,742.47","shares_owned_after":4890355.0,"shares_owned_after_display":"4,890,355","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-02","filed_date":"2018-05-03","scope":"insider"},{"id":6653976,"accession":"0001140361-18-021543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-021543","line_url":"/filing/0001140361-18-021543#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35700.0,"shares_display":"35,700","price_per_share":4.7645,"price_display":"4.76","price_state":"stated","total_value":170092.65,"total_display":"170,092.65","shares_owned_after":4819755.0,"shares_owned_after_display":"4,819,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-03","scope":"insider"},{"id":6653973,"accession":"0001140361-18-021543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-021543","line_url":"/filing/0001140361-18-021543#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14900.0,"shares_display":"14,900","price_per_share":4.825,"price_display":"4.82","price_state":"stated","total_value":71892.5,"total_display":"71,892.50","shares_owned_after":4834655.0,"shares_owned_after_display":"4,834,655","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-03","scope":"insider"},{"id":6627994,"accession":"0001140361-18-020485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-020485","line_url":"/filing/0001140361-18-020485#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":6.175,"price_display":"6.18","price_state":"stated","total_value":617500.0,"total_display":"617,500.00","shares_owned_after":4784055.0,"shares_owned_after_display":"4,784,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-26","filed_date":"2018-04-30","scope":"insider"},{"id":9233504,"accession":"0001140361-18-019696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-019696","line_url":"/filing/0001140361-18-019696#line-2","is_derivative":false,"issuer_cik":"0001325447","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001325447","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121997.0,"shares_display":"121,997","price_per_share":5.9995,"price_display":"6.00","price_state":"stated","total_value":731921.0015,"total_display":"731,921.00","shares_owned_after":4684055.0,"shares_owned_after_display":"4,684,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-26","scope":"insider"},{"id":9233503,"accession":"0001140361-18-019696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-019696","line_url":"/filing/0001140361-18-019696#line-1","is_derivative":false,"issuer_cik":"0001325447","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001325447","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100003.0,"shares_display":"100,003","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":600018.0,"total_display":"600,018.00","shares_owned_after":4562058.0,"shares_owned_after_display":"4,562,058","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-26","scope":"insider"},{"id":6390030,"accession":"0001140361-18-019529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-019529","line_url":"/filing/0001140361-18-019529#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121997.0,"shares_display":"121,997","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":762481.25,"total_display":"762,481.25","shares_owned_after":4684055.0,"shares_owned_after_display":"4,684,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-25","scope":"insider"},{"id":6390026,"accession":"0001140361-18-019529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-019529","line_url":"/filing/0001140361-18-019529#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100003.0,"shares_display":"100,003","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":600018.0,"total_display":"600,018.00","shares_owned_after":4562058.0,"shares_owned_after_display":"4,562,058","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-25","scope":"insider"},{"id":6134664,"accession":"0001140361-18-015242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-015242","line_url":"/filing/0001140361-18-015242#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28449.0,"shares_display":"28,449","price_per_share":6.0498,"price_display":"6.05","price_state":"stated","total_value":172110.7602,"total_display":"172,110.76","shares_owned_after":4462055.0,"shares_owned_after_display":"4,462,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-27","scope":"insider"},{"id":6374523,"accession":"0001140361-18-010092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-010092","line_url":"/filing/0001140361-18-010092#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Investment Management, LLC; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4009.0,"shares_display":"4,009","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":24454.9,"total_display":"24,454.90","shares_owned_after":4433606.0,"shares_owned_after_display":"4,433,606","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-22","filed_date":"2018-02-26","scope":"insider"},{"id":6065757,"accession":"0001140361-18-009244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-009244","line_url":"/filing/0001140361-18-009244#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3120.0,"shares_display":"3,120","price_per_share":6.15,"price_display":"6.15","price_state":"stated","total_value":19188.0,"total_display":"19,188.00","shares_owned_after":4429597.0,"shares_owned_after_display":"4,429,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-21","scope":"insider"},{"id":6065755,"accession":"0001140361-18-009244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-009244","line_url":"/filing/0001140361-18-009244#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":6.2417,"price_display":"6.24","price_state":"stated","total_value":187251.0,"total_display":"187,251.00","shares_owned_after":4426477.0,"shares_owned_after_display":"4,426,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-21","scope":"insider"},{"id":6444468,"accession":"0001140361-18-008694","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14791.0,"shares_display":"14,791","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":92443.75,"total_display":"92,443.75","shares_owned_after":4396477.0,"shares_owned_after_display":"4,396,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-15","scope":"insider"},{"id":6444465,"accession":"0001140361-18-008694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":40625.0,"total_display":"40,625.00","shares_owned_after":4381686.0,"shares_owned_after_display":"4,381,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-14","filed_date":"2018-02-15","scope":"insider"},{"id":6444461,"accession":"0001140361-18-008694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":13125.0,"total_display":"13,125.00","shares_owned_after":4375186.0,"shares_owned_after_display":"4,375,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-13","filed_date":"2018-02-15","scope":"insider"},{"id":6065690,"accession":"0001140361-18-006973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-006973","line_url":"/filing/0001140361-18-006973#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12672.0,"shares_display":"12,672","price_per_share":6.2175,"price_display":"6.22","price_state":"stated","total_value":78788.16,"total_display":"78,788.16","shares_owned_after":4373086.0,"shares_owned_after_display":"4,373,086","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-13","scope":"insider"},{"id":6065686,"accession":"0001140361-18-006973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-006973","line_url":"/filing/0001140361-18-006973#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22600.0,"shares_display":"22,600","price_per_share":6.2051,"price_display":"6.21","price_state":"stated","total_value":140235.26,"total_display":"140,235.26","shares_owned_after":4360414.0,"shares_owned_after_display":"4,360,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-02-13","scope":"insider"},{"id":6627477,"accession":"0001140361-18-006264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-006264","line_url":"/filing/0001140361-18-006264#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":6.3192,"price_display":"6.32","price_state":"stated","total_value":110586.0,"total_display":"110,586.00","shares_owned_after":4337814.0,"shares_owned_after_display":"4,337,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-09","scope":"insider"},{"id":6627472,"accession":"0001140361-18-006264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-006264","line_url":"/filing/0001140361-18-006264#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":6.348,"price_display":"6.35","price_state":"stated","total_value":24122.4,"total_display":"24,122.40","shares_owned_after":4320314.0,"shares_owned_after_display":"4,320,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-07","filed_date":"2018-02-09","scope":"insider"},{"id":6374395,"accession":"0001140361-18-005487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-005487","line_url":"/filing/0001140361-18-005487#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45834.0,"shares_display":"45,834","price_per_share":6.328,"price_display":"6.33","price_state":"stated","total_value":290037.552,"total_display":"290,037.55","shares_owned_after":4316514.0,"shares_owned_after_display":"4,316,514","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-06","filed_date":"2018-02-07","scope":"insider"},{"id":6374391,"accession":"0001140361-18-005487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-005487","line_url":"/filing/0001140361-18-005487#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35498.0,"shares_display":"35,498","price_per_share":6.3256,"price_display":"6.33","price_state":"stated","total_value":224546.1488,"total_display":"224,546.15","shares_owned_after":4265680.0,"shares_owned_after_display":"4,265,680","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6374387,"accession":"0001140361-18-005487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-005487","line_url":"/filing/0001140361-18-005487#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.325,"price_display":"6.32","price_state":"stated","total_value":31625.0,"total_display":"31,625.00","shares_owned_after":4270680.0,"shares_owned_after_display":"4,270,680","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6576831,"accession":"0001140361-18-004930","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-004930","line_url":"/filing/0001140361-18-004930#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35208.0,"shares_display":"35,208","price_per_share":6.5885,"price_display":"6.59","price_state":"stated","total_value":231967.908,"total_display":"231,967.91","shares_owned_after":4219882.0,"shares_owned_after_display":"4,219,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6576827,"accession":"0001140361-18-004930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-004930","line_url":"/filing/0001140361-18-004930#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10300.0,"shares_display":"10,300","price_per_share":6.4757,"price_display":"6.48","price_state":"stated","total_value":66699.71,"total_display":"66,699.71","shares_owned_after":4230182.0,"shares_owned_after_display":"4,230,182","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6576823,"accession":"0001140361-18-004930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-004930","line_url":"/filing/0001140361-18-004930#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":6.475,"price_display":"6.48","price_state":"stated","total_value":2590.0,"total_display":"2,590.00","shares_owned_after":4184674.0,"shares_owned_after_display":"4,184,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":6265845,"accession":"0001140361-18-004372","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42000.0,"shares_display":"42,000","price_per_share":6.8451,"price_display":"6.85","price_state":"stated","total_value":287494.2,"total_display":"287,494.20","shares_owned_after":4477920.0,"shares_owned_after_display":"4,477,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-31","filed_date":"2018-02-01","scope":"insider"},{"id":6265839,"accession":"0001140361-18-004372","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19485.0,"shares_display":"19,485","price_per_share":6.799,"price_display":"6.80","price_state":"stated","total_value":132478.515,"total_display":"132,478.52","shares_owned_after":4435920.0,"shares_owned_after_display":"4,435,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-31","filed_date":"2018-02-01","scope":"insider"},{"id":6265834,"accession":"0001140361-18-004372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13400.0,"shares_display":"13,400","price_per_share":6.825,"price_display":"6.82","price_state":"stated","total_value":91455.0,"total_display":"91,455.00","shares_owned_after":4416435.0,"shares_owned_after_display":"4,416,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6265829,"accession":"0001140361-18-004372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13298.0,"shares_display":"13,298","price_per_share":6.7083,"price_display":"6.71","price_state":"stated","total_value":89206.9734,"total_display":"89,206.97","shares_owned_after":4403035.0,"shares_owned_after_display":"4,403,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":5179058,"accession":"0001140361-17-019221","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19075.0,"shares_display":"19,075","price_per_share":13.0434,"price_display":"13.04","price_state":"stated","total_value":248802.855,"total_display":"248,802.86","shares_owned_after":4389737.0,"shares_owned_after_display":"4,389,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-10","scope":"insider"},{"id":5179051,"accession":"0001140361-17-019221","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13505.0,"shares_display":"13,505","price_per_share":13.0434,"price_display":"13.04","price_state":"stated","total_value":176151.117,"total_display":"176,151.12","shares_owned_after":4408812.0,"shares_owned_after_display":"4,408,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-10","scope":"insider"},{"id":5179047,"accession":"0001140361-17-019221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20477.0,"shares_display":"20,477","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":266201.0,"total_display":"266,201.00","shares_owned_after":4422317.0,"shares_owned_after_display":"4,422,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-08","filed_date":"2017-05-10","scope":"insider"},{"id":5179040,"accession":"0001140361-17-019221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14497.0,"shares_display":"14,497","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":188461.0,"total_display":"188,461.00","shares_owned_after":4442794.0,"shares_owned_after_display":"4,442,794","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-08","filed_date":"2017-05-10","scope":"insider"},{"id":4787858,"accession":"0001140361-17-018386","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3337.0,"shares_display":"3,337","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":43381.0,"total_display":"43,381.00","shares_owned_after":4457291.0,"shares_owned_after_display":"4,457,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-04","scope":"insider"},{"id":4787855,"accession":"0001140361-17-018386","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2363.0,"shares_display":"2,363","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":30719.0,"total_display":"30,719.00","shares_owned_after":4460628.0,"shares_owned_after_display":"4,460,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-04","scope":"insider"},{"id":4787852,"accession":"0001140361-17-018386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18435.0,"shares_display":"18,435","price_per_share":13.3262,"price_display":"13.33","price_state":"stated","total_value":245668.497,"total_display":"245,668.50","shares_owned_after":4462991.0,"shares_owned_after_display":"4,462,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-04","scope":"insider"},{"id":4787849,"accession":"0001140361-17-018386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13052.0,"shares_display":"13,052","price_per_share":13.3262,"price_display":"13.33","price_state":"stated","total_value":173933.5624,"total_display":"173,933.56","shares_owned_after":4481426.0,"shares_owned_after_display":"4,481,426","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-04","scope":"insider"},{"id":4947439,"accession":"0001140361-17-017790","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17641.0,"shares_display":"17,641","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":229333.0,"total_display":"229,333.00","shares_owned_after":4494478.0,"shares_owned_after_display":"4,494,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"},{"id":4947431,"accession":"0001140361-17-017790","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12490.0,"shares_display":"12,490","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":162370.0,"total_display":"162,370.00","shares_owned_after":4512119.0,"shares_owned_after_display":"4,512,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"},{"id":4947427,"accession":"0001140361-17-017790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":13.0169,"price_display":"13.02","price_state":"stated","total_value":23625.6735,"total_display":"23,625.67","shares_owned_after":4524609.0,"shares_owned_after_display":"4,524,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-28","filed_date":"2017-05-02","scope":"insider"},{"id":4947423,"accession":"0001140361-17-017790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1285.0,"shares_display":"1,285","price_per_share":13.0169,"price_display":"13.02","price_state":"stated","total_value":16726.7165,"total_display":"16,726.72","shares_owned_after":4526424.0,"shares_owned_after_display":"4,526,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-28","filed_date":"2017-05-02","scope":"insider"},{"id":5246137,"accession":"0001140361-17-017253","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253#line-4","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31138.0,"shares_display":"31,138","price_per_share":13.0087,"price_display":"13.01","price_state":"stated","total_value":405064.9006,"total_display":"405,064.90","shares_owned_after":4527709.0,"shares_owned_after_display":"4,527,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-28","scope":"insider"},{"id":5246133,"accession":"0001140361-17-017253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22047.0,"shares_display":"22,047","price_per_share":13.0087,"price_display":"13.01","price_state":"stated","total_value":286802.8089,"total_display":"286,802.81","shares_owned_after":4558847.0,"shares_owned_after_display":"4,558,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-28","scope":"insider"},{"id":5246129,"accession":"0001140361-17-017253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37254.0,"shares_display":"37,254","price_per_share":13.0261,"price_display":"13.03","price_state":"stated","total_value":485274.3294,"total_display":"485,274.33","shares_owned_after":4580894.0,"shares_owned_after_display":"4,580,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-28","scope":"insider"},{"id":5246124,"accession":"0001140361-17-017253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26376.0,"shares_display":"26,376","price_per_share":13.0261,"price_display":"13.03","price_state":"stated","total_value":343576.4136,"total_display":"343,576.41","shares_owned_after":4618148.0,"shares_owned_after_display":"4,618,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-28","scope":"insider"},{"id":5140679,"accession":"0001140361-17-016840","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-016840","line_url":"/filing/0001140361-17-016840#line-6","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138617.0,"shares_display":"138,617","price_per_share":13.3368,"price_display":"13.34","price_state":"stated","total_value":1848707.2056,"total_display":"1,848,707.21","shares_owned_after":4644524.0,"shares_owned_after_display":"4,644,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-26","scope":"insider"},{"id":5140674,"accession":"0001140361-17-016840","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-016840","line_url":"/filing/0001140361-17-016840#line-5","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98143.0,"shares_display":"98,143","price_per_share":13.3368,"price_display":"13.34","price_state":"stated","total_value":1308913.5624,"total_display":"1,308,913.56","shares_owned_after":4788996.0,"shares_owned_after_display":"4,788,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-26","scope":"insider"}],"next_cursor":"2017-04-25|5140674","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001082038","name":"DURECT CORP","url":"/issuer/0001082038","role":"Ten percent owner","n_filings":7,"first_seen":"2015-03-20","last_seen":"2019-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001001902","name":"INTEVAC INC","url":"/issuer/0001001902","role":"Ten percent owner","n_filings":20,"first_seen":"2015-12-30","last_seen":"2018-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001013238","name":"ARADIGM CORP","url":"/issuer/0001013238","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2010-06-22","last_seen":"2013-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001459708","retrieved_at":"2026-08-21T18:00:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}